Brand · Tablet · Updated Nov 11, 2026
Tegretol 200 mg tablet price what pharmacies pay, and what you should
Is my price fair?
Check the price you were quoted
Type what the pharmacy asked for tegretol 200 mg tablet and see the markup over what they pay.
A benchmark from public data, not a price offer or medical advice. Prices vary by pharmacy, insurance and discount programs.
Tegretol 200 mg price history
What pharmacies pay for 30 tablets, weekly- Now
- $91.17
- 52-week low
- $88.57
- 52-week high
- $91.28
- A year ago
- $88.87
Why the price changed
| Effective | Before | After | Change | Reason |
|---|---|---|---|---|
| Oct 21, 2026 | $3.04 | $3.04 | No change | pharmacies' invoice prices changed (survey) |
| Sep 23, 2026 | $3.04 | $3.04 | -0.1% | pharmacies' invoice prices changed (survey) |
| Aug 19, 2026 | $3.04 | $3.04 | +0.1% | pharmacies' invoice prices changed (survey) |
| Jul 22, 2026 | $3.04 | $3.04 | No change | pharmacies' invoice prices changed (survey) |
| Jun 17, 2026 | $3.04 | $3.04 | No change | pharmacies' invoice prices changed (survey) |
| May 20, 2026 | $3.04 | $3.04 | -0.1% | pharmacies' invoice prices changed (survey) |
| Jan 7, 2026 | $2.95 | $3.04 | +3.0% | WAC Adjustment |
| Dec 17, 2025 | $2.96 | $2.95 | -0.1% | pharmacies' invoice prices changed (survey) |
Prices per tablet. Reasons are the ones the national survey gives: a survey rate change comes from pharmacies' own invoices; a published price change follows the maker's list price.
What people paid for tegretol 200 mg tablet
What did your pharmacy charge? It takes 30 seconds, it's anonymous - and it shows everyone which pharmacies are fair.
Supply status: shortages & recalls
Shortages
- Carbatrol, Capsule, Extended Release, 100 mg (NDC 54092-171-12)Discontinuation of the manufacture of the drug
- Carbatrol, Capsule, Extended Release, 300 mg (NDC 54092-173-12)Discontinuation of the manufacture of the drug
- Carbatrol, Capsule, Extended Release, 200 mg (NDC 54092-172-12)Discontinuation of the manufacture of the drug
In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.
Recalls
Showing the 6 most relevant of 14 - all recalls.
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
Every manufacturer and package code
1 company sell tegretol 200 mg tablet under 1 package code (NDC).
| Maker | Package codes | Per unit |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 0078-0509-05 | $3.04 |
All 1 package codes
A dash means no weekly price for that maker's packages. Which maker your pharmacy stocks usually doesn't change what you pay, but you can ask.
The generic costs 25x less
Questions to ask your pharmacist
- "Is the generic right for me?" The generic, carbamazepine 200 mg tablet, costs pharmacies $3.58 for 30 tablets.
- "What is your cash price, without insurance?" For low-cost generics it can be less than a copay.
- "Is a 90-day supply cheaper per tablet?" Dispensing fees are charged per fill, so fewer fills often cost less.
- "Do you match other pharmacies or accept discount cards?" Many do, if you ask.
These are questions, not advice. Never change how you take a medicine without talking to your prescriber or pharmacist.
Other tegretol strengths and forms
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 100 mg (12 hr) extended-release tablet Brand | $1.63 | $48.79 / 30 tablets |
| 200 mg (12 hr) extended-release tablet Brand | $3.24 | $97.33 / 30 tablets |
| 400 mg (12 hr) extended-release tablet Brand | $6.49 | $194.71 / 30 tablets |
| 20 mg/mL oral suspension Brand | $0.4365 | $196.40 / 450 mL |
Official label & what changed
Tegretol
WARNINGS
SERIOUS DERMATOLOGIC REACTIONS AND HLA-B*1502 ALLELE
SERIOUS AND SOMETIMES FATAL DERMATOLOGIC REACTIONS, INCLUDING TOXIC EPIDERMAL NECROLYSIS (TEN) AND STEVENS-JOHNSON SYNDROME (SJS), HAVE BEEN REPORTED DURING TREATMENT WITH TEGRETOL. THESE REACTIONS ARE ESTIMATED TO OCCUR IN 1 TO 6 PER 10,000 NEW USERS IN COUNTRIES WITH MAINLY CAUCASIAN POPULATIONS, BUT THE RISK IN SOME ASIAN COUNTRIES IS ESTIMATED TO BE ABOUT 10 TIMES HIGHER. STUDIES IN PATIENTS OF CHINESE ANCESTRY HAVE FOUND A STRONG ASSOCIATION BETWEEN THE RISK OF DEVELOPING SJS/TEN AND THE PRESENCE OF HLA-B*1502, AN INHERITED ALLELIC VARIANT OF THE HLA-B GENE. HLA-B*1502 IS FOUND ALMOST EXCLUSIVELY IN PATIENTS WITH ANCESTRY ACROSS BROAD AREAS OF ASIA. PATIENTS WITH ANCESTRY IN GENETICALLY AT-RISK POPULATIONS SHOULD BE SCREENED FOR THE PRESENCE OF HLA-B*1502 PRIOR TO INITIATING TREATMENT WITH TEGRETOL. PATIENTS TESTING POSITIVE FOR THE ALLELE SHOULD NOT BE TREATED WITH TEGRETOL UNLESS THE BENEFIT CLEARLY OUTWEIGHS THE RISK (SEE WARNINGS AND PRECAUTIONS, LABORATORY TESTS).
APLASTIC ANEMIA AND AGRANULOCYTOSIS
APLASTIC ANEMIA AND AGRANULOCYTOSIS HAVE BEEN REPORTED IN ASSOCIATION WITH THE USE OF TEGRETOL. DATA FROM A POPULATION-BASED CASE CONTROL STUDY DEMONSTRATE THAT THE RISK OF DEVELOPING THESE REACTIONS IS 5 TO 8 TIMES GREATER THAN IN THE GENERAL POPULATION. HOWEVER, THE OVERALL RISK OF THESE REACTIONS IN THE UNTREATED GENERAL POPULATION IS LOW, APPROXIMATELY SIX PATIENTS PER ONE MILLION POPULATION PER YEAR FOR AGRANULOCYTOSIS AND TWO PATIENTS PER ONE MILLION POPULATION PER YEAR FOR APLASTIC ANEMIA.
ALTHOUGH REPORTS OF TRANSIENT OR PERSISTENT DECREASED PLATELET OR WHITE BLOOD CELL COUNTS ARE NOT UNCOMMON IN ASSOCIATION WITH THE USE OF TEGRETOL, DATA ARE NOT AVAILABLE TO ESTIMATE ACCURATELY THEIR INCIDENCE OR OUTCOME. HOWEVER, THE VAST MAJORITY OF THE CASES OF LEUKOPENIA HAVE NOT PROGRESSED TO THE MORE SERIOUS CONDITIONS OF APLASTIC ANEMIA OR AGRANULOCYTOSIS.
BECAUSE OF THE VERY LOW INCIDENCE OF AGRANULOCYTOSIS AND APLASTIC ANEMIA, THE VAST MAJORITY OF MINOR HEMATOLOGIC CHANGES OBSERVED IN MONITORING OF PATIENTS ON TEGRETOL ARE UNLIKELY TO SIGNAL THE OCCURRENCE OF EITHER ABNORMALITY. NONETHELESS, COMPLETE PRETREATMENT HEMATOLOGICAL TESTING SHOULD BE OBTAINED AS A BASELINE. IF A PATIENT IN THE COURSE OF TREATMENT EXHIBITS LOW OR DECREASED WHITE BLOOD CELL OR PLATELET COUNTS, THE PATIENT SHOULD BE MONITORED CLOSELY. DISCONTINUATION OF THE DRUG SHOULD BE CONSIDERED IF ANY EVIDENCE OF SIGNIFICANT BONE MARROW DEPRESSION DEVELOPS.
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Questions about tegretol 200 mg tablet
How much does tegretol 200 mg tablet cost without insurance?
Pharmacies pay about $91.17 for 30 tablets ($3.04 per tablet) as of November 11, 2026. A fair cash price is about $115.35: that cost plus a 15% margin and a $10.50 dispensing fee. Online cost-plus pharmacies charge around $114.85 including shipping.
Is my price for tegretol 200 mg tablet fair?
Compare it with the fair cash price of $115.35 for 30 tablets. Up to about $144.19 is fair; above $230.70 is high, and worth asking the pharmacy for its cash price or trying another pharmacy. Check your quote.
Is tegretol 200 mg tablet getting more expensive?
Over the last four weeks the price pharmacies pay held steady. Over a year it rose 2.6%. See the 52-week chart.
Is there a cheaper generic of Tegretol 200 mg tablet?
Yes: carbamazepine 200 mg tablet, which pharmacies get for $3.58 for the same amount.
Who makes tegretol 200 mg tablet?
1 company: Novartis Pharmaceuticals Corporation. See every package code.
Is tegretol in shortage?
Yes - 3 products are listed as short or being discontinued. Details.
Has tegretol been recalled?
14 recalls on record. Recalls name specific lots - check yours.
What does "pharmacies pay" mean?
It's the national average price retail pharmacies pay wholesalers and makers to buy the drug, from a weekly government survey of pharmacy invoices. It doesn't include the pharmacy's costs of filling a prescription, which is why the fair price adds a margin and a dispensing fee. How we work it out.
Talk about tegretol 200 mg tablet
No comments yet. Questions, tips, what worked for you - start the conversation.